Ayano Katagiri Selected Research

Ayano Katagiri Research Topics

Disease

8	Pain (Aches) 06/2023 - 01/2012
6	Hypersensitivity (Allergy) 01/2024 - 01/2017
6	Hyperalgesia 01/2024 - 05/2011
5	Neuralgia (Stump Neuralgia) 01/2019 - 03/2012
3	Parkinson Disease (Parkinson's Disease) 01/2024 - 12/2020
3	Trigeminal Nerve Injuries 01/2020 - 09/2017
3	Facial Pain (Myofacial Pain) 08/2015 - 05/2011
3	Inflammation (Inflammations) 08/2015 - 05/2011
2	Hypoxia (Hypoxemia) 01/2024 - 10/2022
2	Dry Eye Syndromes (Dry Eye Syndrome) 06/2023 - 01/2023
2	Burning Mouth Syndrome (Syndrome, Burning Mouth) 12/2015 - 07/2011
1	Prodromal Symptoms 01/2022
1	Polydipsia 12/2021
1	Nervous System Diseases (Neurological Disorders) 12/2020
1	Cognitive Dysfunction 12/2020
1	Chronic Pain 07/2013

Drug/Important Bio-Agent (IBA)

5	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2019 - 01/2012
4	Capsaicin (Zostrix)FDA Link 01/2024 - 01/2019
4	Calcitonin Gene-Related PeptideIBA 01/2024 - 09/2017
3	RotenoneIBA 01/2024 - 12/2020
3	Glial Fibrillary Acidic ProteinIBA 09/2017 - 03/2012
3	Freund's AdjuvantIBA 08/2015 - 05/2011
2	Menthol FDA Link 01/2024 - 12/2021
2	diquafosolIBA 06/2023 - 01/2023
2	SodiumIBA 06/2023 - 01/2023
2	Purinergic P2Y2 ReceptorsIBA 06/2023 - 01/2023
2	NeuropeptidesIBA 09/2017 - 01/2017
2	Mitogen-Activated Protein KinasesIBA 01/2013 - 09/2011
1	Calcitonin Gene-Related Peptide Receptor AntagonistsIBA 01/2024
1	Streptozocin (Streptozotocin)FDA Link 12/2021
1	PesticidesIBA 12/2020
1	salicylhydroxamic acid (SHAM)IBA 01/2019
1	Glutamine (L-Glutamine)FDA Link 01/2018
1	methylthio-ADPIBA 12/2017
1	2-methylthioadenosineIBA 12/2017
1	2,2-dimethylpropionic acid 3- (2- chloro- 6- methylaminopurin- 9- yl)- 2- (2,2- dimethylpropionyloxymethyl)propyl esterIBA 12/2017
1	SaltsIBA 12/2017
1	Mitogen-Activated Protein Kinase 3IBA 12/2017
1	Purinergic P2Y Receptor AntagonistsIBA 12/2017
1	Hormones (Hormone)IBA 01/2017
1	Oxytocin (Pitocin)FDA LinkGeneric 01/2017
1	Messenger RNA (mRNA)IBA 12/2015
1	Sulfonic AcidsIBA 12/2015
1	Ethanol (Ethyl Alcohol)IBA 12/2015
1	sym-trinitrobenzeneIBA 12/2015
1	N- (3- methoxyphenyl)- 4- chlorocinnamanilideIBA 12/2015
1	SB 203580IBA 08/2015
1	OrexinsIBA 08/2014
1	Estrogens (Estrogen)FDA Link 07/2013
1	Protein Kinases (Protein Kinase)IBA 01/2013
1	Phosphotransferases (Kinase)IBA 11/2012
1	Metabotropic Glutamate 5 ReceptorIBA 11/2012
1	AMPA Receptors (AMPA Receptor)IBA 01/2012
1	Formaldehyde (Formol)FDA Link 01/2012
1	alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)IBA 01/2012
1	Ionotropic Glutamate ReceptorsIBA 09/2011
1	Milnacipran (Ixel)FDA Link 07/2011
1	staurosporine aglycone (K252a)IBA 05/2011
1	Nerve Growth Factor (NGF)IBA 05/2011
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 05/2011

Therapy/Procedure

1	Ligation 01/2017